Cargando…

Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane–PLD versus PLD–Taxane in Patients with Metastatic Breast Cancer

SIMPLE SUMMARY: Patients with breast cancer, that has spread and does not respond to hormone treatment, are usually treated with chemotherapy. If one kind of chemotherapy fails, another kind is started. There are various options and different chemotherapies to choose, but currently there is no stand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallrabenstein, Till, Oseledchyk, Anton, Daetwyler, Eveline, Rochlitz, Christoph, Vetter, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605604/ https://www.ncbi.nlm.nih.gov/pubmed/37894320 http://dx.doi.org/10.3390/cancers15204953

Ejemplares similares

Pegylated liposomal doxorubicin (PLD) in daily practice—A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer
por: Wallrabenstein, T., et al.
Publicado: (2023)

Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo
por: Yuan, Y, et al.
Publicado: (2008)

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
por: O’Donnell, Robert T., et al.
Publicado: (2009)

Data on prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer: Post-hoc data analysis from the phase 3 randomized, open-label study comparing trabectedin and PLD versus PLD alone in patients with recurrent ovarian cancer
por: Monk, Bradley J., et al.
Publicado: (2020)

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
por: Valle, J W, et al.
Publicado: (2005)

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial
por: Fiegl, Michael, et al.
Publicado: (2011)

A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy
por: Stearns, V, et al.
Publicado: (2009)

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

PLD1 and PLD2 differentially regulate the balance of macrophage polarization in inflammation and tissue injury
por: Hwang, Won Chan, et al.
Publicado: (2020)

Cleavage of DNA and RNA by PLD3 and PLD4 limits autoinflammatory triggering by multiple sensors
por: Gavin, Amanda L., et al.
Publicado: (2021)

PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing
por: Gavin, Amanda L., et al.
Publicado: (2018)

Digital devices and systems with PLD applications /
por: Miller, Michael A.
Publicado: (1997)

Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Vici, Patrizia, et al.
Publicado: (2014)

Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
por: Runnebaum, Ingo B., et al.
Publicado: (2018)

PLD4 Is Involved in Phagocytosis of Microglia: Expression and Localization Changes of PLD4 Are Correlated with Activation State of Microglia
por: Otani, Yoshinori, et al.
Publicado: (2011)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group
por: Bafaloukos, D, et al.
Publicado: (2004)

Dopamine-Induced Plasticity, Phospholipase D (PLD) Activity and Cocaine-Cue Behavior Depend on PLD-Linked Metabotropic Glutamate Receptors in Amygdala
por: Krishnan, Balaji, et al.
Publicado: (2011)

Pegylated liposomal doxorubicin (PLD)-containing regimen as a novel treatment of monomorphic epithelial intestinal T-cell lymphoma (MEITL): A case report and review of literature
por: Chen, Yue, et al.
Publicado: (2022)

PLD gives nutritional advice to mTORC1
por: Short, Ben
Publicado: (2011)

PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease
por: Blanco-Luquin, Idoia, et al.
Publicado: (2018)

CsPLDα1 and CsPLDγ1 are differentially induced during leaf and fruit abscission and diurnally regulated in Citrus sinensis
por: Malladi, Anish, et al.
Publicado: (2008)

Delivery of the Pseudomonas aeruginosa Phospholipase Effectors PldA and PldB in a VgrG- and H2-T6SS-Dependent Manner
por: Wettstadt, Sarah, et al.
Publicado: (2019)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
por: Colombo, N., et al.
Publicado: (2023)

PLD based design with VHDL: RTL design, synthesis and implementation
por: Taraate, Vaibbhav
Publicado: (2017)

Time-to-digital Convertor with Nanosecond Resolution Based on the PLD Altera
por: Bukin, M A, et al.
Publicado: (2001)

PLD3 is accumulated on neuritic plaques in Alzheimer’s disease brains
por: Satoh, Jun-ichi, et al.
Publicado: (2014)

PLD1 participates in BDNF-induced signalling in cortical neurons
por: Ammar, Mohamed Raafet, et al.
Publicado: (2015)

Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages
por: Zarrow, Jonah E., et al.
Publicado: (2023)

PLD plasma plume analysis: a summary of the PSI contribution
por: Schneider, Christof W., et al.
Publicado: (2023)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
por: Anoop, T M, et al.
Publicado: (2022)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Sex Differences in Taxane Toxicities
por: Chmielewski, Nicole N., et al.
Publicado: (2022)

Description of PLD'S used in the LINAC 3 ECR source controls interface
por: Evans, B J
Publicado: (1994)

PLD-dependent phosphatidic acid microdomains are signaling platforms for podosome formation
por: Bolomini-Vittori, Matteo, et al.
Publicado: (2019)

Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism
por: Lefort, Charlotte, et al.
Publicado: (2020)

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease
por: Yuan, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n92q7nbr8t3q60965lef5io9j6